ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

9.28

-0.06 (-0.64%)

At close: Feb 27, 2026, 4:00 PM EST

9.29

+0.01 (0.11%)

After-hours: Feb 27, 2026, 5:17 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Pharmaceuticals	89.15M	30.00K	1.32M	5.51M	17.84M
Pharmaceuticals Growth	297063.33%	-97.72%	-76.10%	-69.13%	-
Total	89.15M	30.00K	1.32M	5.51M	17.84M
Total Growth	297063.33%	-97.72%	-76.10%	-69.13%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	89.15M	30.00K	1.32M	5.51M	17.84M
United States Growth	297063.33%	-97.72%	-76.10%	-69.13%	-
Total	89.15M	30.00K	1.32M	5.51M	17.84M
Total Growth	297063.33%	-97.72%	-76.10%	-69.13%	-

Source: S&P Global Market Intelligence.